(20-March-2005) The US FDA has issued approval for Symlin, an injectable medicine to control blood sugar for adults with type 1 and type 2 diabetes, manufactured by Amylin Pharmaceuticals, Inc. Symlin is to be used in addition to insulin therapy in patients who cannot achieve adequate control of their blood sugars on intensive insulin therapy alone.

(20-March-2005) Like pieces of origami that get mangled during folding, some insulin molecules get produced in bungled forms — as well as the correct form — inside the cells of the pancreas, new research shows.

(20-March-2005) In patients with type 2 diabetes mellitus, is atorvastatin better than placebo for primary prevention of major cardiovascular disease (CVD) events?

(19-March-2005) Palatin Technologies Inc. and King Pharmaceuticals Inc. on Friday said men taking their experimental impotence treatment in combination with Pfizer Inc.'s Viagra in a small clinical trial had significantly longer-lasting erections than those who only took Viagra.

(19-March-2005/Reuters) The British government said on Saturday it had asked for an assessment of its decision to ease the rules on cannabis after studies showed the drug's use may be linked to mental health problems.

(17-March-2005/Reuters) Using new methods to make influenza vaccines instead of the current egg-based approach could cut production time in half in case of an outbreak of deadly avian flu, U.S. researchers said on Wednesday.

(10-March-2005/Reuters) The rate of serious muscle damage reported in patients who took AstraZeneca Plc's cholesterol drug Crestor was six times higher than with similar medicines, a consumer group said on Thursday.

(10-March-2005/AP)Giving heart attack patients Plavix on top of the anti-clotting drugs they usually receive greatly reduces the chances they'll die or suffer another heart attack, landmark new research has found

(9-March-2005)Thinking of treating your child's illness with herbal supplements? You may want to do some fact-checking and talk it over with a doctor first.

(9-March-2005/AFP)Heart attack risk and cardio-vascular complications can be reduced by 25 and 15 percent respectively thanks to a combination of new drugs aimed to beat high blood pressure, preliminary results of an international study revealed.

(9-March-2005/Reuters) Sanofi-Aventis SA's expe- rimental obesity drug helped patients shed three times as much weight as those on a placebo, but patients gained some of that weight back in the second year, according to a study released on Tuesday.

(9-March-2005/DenverPost)A man who suffered a heart attack after taking the painkiller Vioxx sued its manufacturer Tuesday in federal court in Denver.